BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9490466)

  • 1. [Ovarian cancer: the symptoms and pathology. The cases of the Cantonal Cancer Registry (1989-1995)].
    Petignat P; Gaudin G; Vajda D; Joris F; Obrist R
    Schweiz Med Wochenschr; 1997 Nov; 127(48):1993-9. PubMed ID: 9490466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Presenting symptoms of epithelial ovarian cancer.
    Lataifeh I; Marsden DE; Robertson G; Gebski V; Hacker NF
    Aust N Z J Obstet Gynaecol; 2005 Jun; 45(3):211-4. PubMed ID: 15904446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Women's awareness of ovarian cancer risks and symptoms.
    Lockwood-Rayermann S; Donovan HS; Rambo D; Kuo CW
    Am J Nurs; 2009 Sep; 109(9):36-45; quiz 46. PubMed ID: 19704232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early symptoms of ovarian cancer: a case-control study without recall bias.
    Friedman GD; Skilling JS; Udaltsova NV; Smith LH
    Fam Pract; 2005 Oct; 22(5):548-53. PubMed ID: 15964871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Advances in the management of epithelial ovarian cancer.
    Berkenblit A; Cannistra SA
    J Reprod Med; 2005 Jun; 50(6):426-38. PubMed ID: 16050567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical picture of women with early stage ovarian cancer.
    Eltabbakh GH; Yadav PR; Morgan A
    Gynecol Oncol; 1999 Dec; 75(3):476-9. PubMed ID: 10600311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relapse and survival in early-stage ovarian cancer.
    Lenhard SM; Bufe A; Kümper C; Stieber P; Mayr D; Hertlein L; Kirschenhofer A; Friese K; Burges A
    Arch Gynecol Obstet; 2009 Jul; 280(1):71-7. PubMed ID: 19093129
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical factors and biomarkers in ovarian tumors development.
    Vrabie CD; Petrescu A; Waller M; Dina I
    Rom J Morphol Embryol; 2008; 49(3):327-38. PubMed ID: 18758637
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ovarian cancer: can we make the clinical diagnosis earlier?
    Smith LH; Morris CR; Yasmeen S; Parikh-Patel A; Cress RD; Romano PS
    Cancer; 2005 Oct; 104(7):1398-407. PubMed ID: 16116591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Laryngeal cancer patients: analysis of patient delay at different tumor stages.
    Brouha XD; Tromp DM; de Leeuw JR; Hordijk GJ; Winnubst JA
    Head Neck; 2005 Apr; 27(4):289-95. PubMed ID: 15668927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differences in symptoms between patients with benign and malignant ovarian neoplasms.
    Attanucci CA; Ball HG; Zweizig SL; Chen AH
    Am J Obstet Gynecol; 2004 May; 190(5):1435-7. PubMed ID: 15167861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How relevant are ACOG and SGO guidelines for referral of adnexal mass?
    Dearking AC; Aletti GD; McGree ME; Weaver AL; Sommerfield MK; Cliby WA
    Obstet Gynecol; 2007 Oct; 110(4):841-8. PubMed ID: 17906018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary and metastatic ovarian cancer in patients with prior breast carcinoma. Pre-operative markers and treatment results.
    Tserkezoglou A; Kontou S; Hadjieleftheriou G; Apostolikas N; Vassilomanolakis M; Sikiotis K; Salamalekis E; Tseke P; Magiakos G
    Anticancer Res; 2006; 26(3B):2339-44. PubMed ID: 16821613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Venous thromboembolism in ovarian cancer.
    Rodriguez AO; Wun T; Chew H; Zhou H; Harvey D; White RH
    Gynecol Oncol; 2007 Jun; 105(3):784-90. PubMed ID: 17408726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Non-genital tract metastases to the ovaries presented as ovarian tumors in Sweden 1990-2003: occurrence, origin and survival compared to ovarian cancer.
    Skírnisdóttir I; Garmo H; Holmberg L
    Gynecol Oncol; 2007 Apr; 105(1):166-71. PubMed ID: 17184826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patients with double primary tumors in the breast and ovary- clinical characteristics and BRCA1-2 mutations status.
    Fishman A; Dekel E; Chetrit A; Lerner-Geva L; Bar-Am A; Beck D; Beller U; Ben-Baruch G; Piura B; Friedman E; Struewing JP; Modan B
    Gynecol Oncol; 2000 Oct; 79(1):74-8. PubMed ID: 11006035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study.
    Vernooij F; Heintz AP; Witteveen PO; van der Heiden-van der Loo M; Coebergh JW; van der Graaf Y
    J Natl Cancer Inst; 2008 Mar; 100(6):399-406. PubMed ID: 18334710
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A population-based study of patterns of care for ovarian cancer: who is seen by a gynecologic oncologist and who is not?
    Carney ME; Lancaster JM; Ford C; Tsodikov A; Wiggins CL
    Gynecol Oncol; 2002 Jan; 84(1):36-42. PubMed ID: 11748973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the time interval between diagnoses in women with double primary breast and ovarian or primary peritoneal cancers.
    Olawaiye A; Caesar L; Walsh D; Lyman M; Yeh J; Rodabaugh K; Marchetti D; Lele S; Odunsi K
    Gynecol Oncol; 2004 Sep; 94(3):796-802. PubMed ID: 15350375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.